FDA approves Merck s cancer drug (Trentonian)
WASHINGTON -- A Merck & Co. Inc. drug received federal approval Friday to treat a slow-growing cancer that affects infection-fighting white blood cells.

FDA facing manpower shortage (The Clarion-Ledger)
WASHINGTON All is not well at the Food and Drug Administration, something made clear by the recent spinach scare. The FDA shut down the spinach market from coast to coast for two weeks while it struggled to control the E. coli outbreak and still hasn't pinpointed the cause of the contamination.